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Abstract 
Background: Depressed individuals often refuse or withdraw from help, a phenomenon termed help-
negation, which is a risk factor for poor outcomes. Most previous research has investigated psychosocial 
factors including stigma as causes of low help-seeking intentions for depression, however these do not 
adequately explain the problem. We hypothesised that because help-negation worsens with symptom 
severity, it might be linked to important biological changes associated with depression itself. We 
investigated the relative contributions of cortisol, a stress hormone linked to depression, and oxytocin, a 
hormone which mediates social behaviours, alongside psychosocial factors, to help-seeking intentions 
among depressed and non-depressed individuals. Methods: Morning plasma cortisol and oxytocin levels, 
psychopathology, suicidal ideation, help-seeking intentions from informal sources including family and 
friends, and formal sources including health professionals, and perceived social support were quantified 
in 63 adults meeting DSM-5 criteria for major depressive disorder (MDD) who were not receiving any 
treatment, and 60 healthy controls. Between-group analyses of variance, correlations, and hierarchical 
multiple regressions were employed. Results: Help-seeking intentions were lower in depressed than 
healthy participants, negatively correlated to cortisol and positively correlated to oxytocin. Cortisol 
negatively, and oxytocin positively, predicted helpseeking intentions from informal but not formal sources, 
after controlling for psychopathology and psychosocial factors. Conclusions: Neuroendocrine changes 
associated with depression may contribute to low help-seeking from friends and family, which may have 
implications for interpersonal support and outcomes. Research and clinical approaches which 
incorporate biological as well as psychosocial factors may allow for more targeted and effective early 
interventions to address lack of help-seeking and depression progression. 
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Background: Depressed individuals often refuse or withdraw from help, a phenomenon 
termed help-negation, which is a risk factor for poor outcomes. Most previous research has 
investigated psychosocial factors including stigma as causes of low help-seeking intentions 
for depression, however these do not adequately explain the problem. We hypothesised that 
because help-negation worsens with symptom severity, it might be linked to important 
biological changes associated with depression itself. We investigated the relative 
contributions of cortisol, a stress hormone linked to depression, and oxytocin, a hormone 
which mediates social behaviours, alongside psychosocial factors, to help-seeking intentions 
among depressed and non-depressed individuals.  
Methods: Morning plasma cortisol and oxytocin levels, psychopathology, suicidal ideation, 
help-seeking intentions from informal sources including family and friends, and formal 
sources including health professionals, and perceived social support were quantified in 63 
adults meeting DSM-5 criteria for major depressive disorder (MDD) who were not receiving 
any treatment, and 60 healthy controls. Between-group analyses of variance, correlations, and 
hierarchical multiple regressions were employed. 
Results: Help-seeking intentions were lower in depressed than healthy participants, negatively 
correlated to cortisol and positively correlated to oxytocin. Cortisol negatively, and oxytocin 
positively, predicted help-seeking intentions from informal but not formal sources, after 
controlling for psychopathology and psychosocial factors.   
Conclusions: Neuroendocrine changes associated with depression may contribute to low help-
seeking from friends and family, which may have implications for interpersonal support and 
outcomes. Research and clinical approaches which incorporate biological as well as 
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psychosocial factors may allow for more targeted and effective early interventions to address 




1. Introduction  
Depressive disorders and suicide are leading causes of morbidity worldwide, and their 
magnitude is increasing (Whiteford et al., 2013). Early treatment reduces long term 
impairment and is cost effective (Chisholm et al., 2004), however, large scale research 
spanning numerous countries and including thousands of participants shows that most people 
with major depressive disorder (MDD) do not receive treatment, even where effective 
treatments are available (Kocsis et al., 2008; Thornicroft et al., 2017). Reasons for the under-
treatment of depression are multi-factorial, however a major contributing factor is a 
widespread reluctance of affected people to seek help (Kocsis et al., 2008; Thornicroft et al., 
2017). This refusal of, or withdrawal from, help has been termed help-negation (Clark and 
Fawcett, 1992; Rudd et al., 1995) and is considered the most difficult barrier to the treatment 
of depression (Han et al., 2006).   
 
Previous research differentiates between help-seeking from informal sources including friends 
and family, and formal sources including health care professionals and helplines. Most 
previous studies of help-seeking for mental health problems have involved sub-clinical 
student populations, who prefer seeking informal rather than formal help (Thomas et al., 
2014). A large-scale epidemiological study also found a general preference for informal 
sources of help, and that the presence of depressive symptoms was associated with lower 
intentions to seek help from family and friends, but no differences in formal help-seeking 
intentions (Chin et al., 2015). It is important to consider informal supports, because friends 
and family often facilitate treatment uptake and adherence in those with depressive symptoms 
(Chin et al., 2015; Lindsey et al., 2010), and are important points of intervention in suicidal 




It has traditionally been assumed that psychosocial factors underlie the widespread reluctance 
of people to seek help for depression, and much research has examined the contributions of 
factors such as stigma or embarrassment, however these seem to be only weakly negatively 
associated with help-seeking (Clement et al., 2015). There is no clear evidence to demonstrate 
that campaigns to increase treatment uptake through targeting stigma are successful 
(Dumesnil and Verger, 2009; Henderson et al., 2013). Additionally, somewhat 
counterintuitively, avoidance of treatment for depressive symptoms and psychological distress 
is greater in individuals with greater psychopathology, stress levels, and suicidal ideation (e.g. 
Carlton and Deane, 2000; Rudd et al., 1995; Sawyer et al., 2012). These factors lead us to 
propose that help-negation might be related to biological, particularly neuroendocrine, 
changes associated with the onset or progress of depression itself, which may be linked to 
interpersonal difficulties and social withdrawal. To date there has been little examination of 
relationships between help-seeking intentions, psychopathology and biological factors. 
Overlooking the contribution of biological factors to help-negation may account for the sub-
optimal success of treatment uptake campaigns targeting psychosocial factors, and further 
research is needed. 
  
Cortisol, an output of the hypothalamus-pituitary-adrenal (HPA) axis, is a consistent 
neurobiological indicator of stress, anxiety and depression (Levine et al., 2007). Prolonged 
HPA hyperactivity through chronic stress is related to cognitive impairment (Lupien et al., 
2009), social withdrawal behaviour (Tops et al., 2005) and mood changes (Sapolsky, 2000). 
Excess cortisol is a risk factor for developing MDD, and those with MDD often have 
disturbances in diurnal cortisol rhythms, increased resistance to the feedback action of 
glucocorticoids, higher basal levels and cortisol awakening response (Herbert, 2013). There 
are indications that individuals with higher basal cortisol display both reduced closeness and 
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that others desire to be less close to them (Ketay et al., 2017). Individuals with severe MDD 
often show increased HPA-axis activity, which normalises during successful antidepressant 
pharmacotherapy (Barden et al., 1995). Anti-depressants might elevate mood in MDD 
through their long-term effects on HPA regulation (Barden et al., 1995). Depression-like 
withdrawal and immobility can be induced in laboratory animals (Kulkarni and Dhir, 2007), 
indicating that it can occur without language-based cognition, which implies a role for 
physiological processes. Vegetative symptoms in depression may stem from processes that 
evolved to preserve energy during insurmountable stress (Gilbert, 2001; Hart, 1988; Tsiouris, 
2005). When placed in stressful situations from which escape is not possible, animals will 
initially struggle and try to escape, but eventually develop immobility, a failure to persist in 
active forms of coping with stressful stimuli. This passive behaviour is termed behavioural 
despair, which is believed to be equivalent to depression (Porsolt et al., 1977), and it is 
reversed with selective-serotonin reuptake inhibitors and with tricyclic antidepressants 
(Kulkarni and Dhir, 2007). Cortisol levels may therefore be related to help-negation and to 
depressive symptoms including vegetative symptoms, social withdrawal and cognitive 
impairment. Relationships between cortisol levels, help-negation and symptom severity are 
not yet known. 
 
Oxytocin is a  hormone which mediates a range of complex social behaviours relevant to 
group-living mammals, including attachment, trust, and social support-seeking and in some 
circumstances aggression (Heinrichs et al., 2009; Smith et al., 2017). Oxytocin is also 
implicated in depression (Viero et al., 2010). It may therefore help to explain help-negation as 
symptoms worsen in MDD. Oxytocin is a nonapeptide hormone which is synthesised in 
hypothalamic nuclei and released directly into the bloodstream from axon terminals in the 
posterior pituitary (MacDonald and MacDonald, 2010). Oxytocin is also transported from the 
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hypothalamus to key brain areas, where it acts as a neurotransmitter (MacDonald and 
MacDonald, 2010). Central effects of oxytocin include inhibition of stress-induced 
hypothalamus-pituitary-adrenal (HPA) axis responsiveness, promotion of social behaviours, 
and anti-depressant effects (Scantamburlo et al., 2007). Oxytocin is implicated in numerous 
psychopathologies characterised by social discomfort, including depression, anxiety and 
psychoses (Viero et al., 2010). Some symptoms of depression (social withdrawal, reduced eye 
contact and low libido) may reflect blunted oxytocin function (Neumann, 2008). Help-
seeking, particularly informally, usually involves interpersonal exchanges. Because oxytocin 
is often inversely related to depressive symptoms, anxiety and stress (Scantamburlo et al., 
2007), and modulates social withdrawal and stress coping (Pompili et al., 2010), oxytocin 
abnormalities may be related to help-negation in MDD. This possibility has yet to be 
examined. 
 
Given the clear involvement of biological processes in depression and withdrawal behaviour, 




represent modifiable risk factors for help-negation which potentially could be targeted in 
novel interventions. The current study examined biological processes in connection with 
symptom severity and help-seeking intentions in depressed and healthy individuals.  
Based on previous research, it was predicted that:  
1. Help-seeking intentions, particularly from informal sources, would be lower in 
participants with MDD than healthy controls.   
2. Cortisol will be negatively related to help-seeking intentions and perceived social 
support and positively related to psychopathology, and the opposite patterns would be 
observed for oxytocin. 
3. Cortisol and oxytocin levels would be more closely related to informal than formal 
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help-seeking intentions, as these involve more socially based interpersonal interactions. 
4. Cortisol and oxytocin would both uniquely predict variance in help-seeking intentions, 
after accounting for levels of psychopathology and perceived social support.   
2. Methods 
2.1 Participants  
The protocol was approved by the local ethics committee, and all participants gave informed 
written consent. Sixty-three adults were recruited who met the DSM-5 diagnostic criteria for 
MDD, were not currently receiving treatment and had not recently had any treatment, along 
with 60 healthy controls. Participants were recruited through advertisements in local media 
and notices at the university. Exclusion criteria across groups included neurological disorders, 
substance use disorders, and use of corticosteroid medication. Participants were screened 
prior to the study with regard to exclusion criteria, and to ensure that depressed participants 
likely met DSM-5 criteria for MDD and healthy controls had no significant mental health 
problems. Depressed participants were also interviewed by a clinical psychologist on arrival 
at the clinical trials unit to confirm that they met DSM-5 diagnostic criteria for major 
depressive disorder, using the Mini International Neuropsychiatric Interview (Lecrubier et al., 
1997), and to ascertain treatment history and reasons for not being in treatment. Participants 
received a store voucher of small value as a reimbursement for their time and inconvenience.  
2.2 Measures  
All participants completed the following measures: The Depression, Anxiety and Stress 
Scales-21 (Lovibond and Lovibond, 1995), an overall measure of psychological distress 
incorporating Depression, Anxiety and Stress subscales. The General Help-Seeking 
Questionnaire-Vignette version (Wilson et al., 2005), a measure of intentions to seek help in 
the event of mental health problems. Participants indicate on a 7-point Likert scale how likely 
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they would be to seek help for depressive symptoms from specific informal (e.g. friends, 
family, partner) and formal (e.g. doctor, psychologist, helpline) sources if they were 
experiencing the same problems as the person in the vignette (1= Extremely unlikely, 3 = 
Unlikely, 5 = Likely, 7 = Extremely likely). The Interpersonal Support Evaluation List-12 
(Cohen et al., 1985), which yields a total score measuring perceived social support, and three 
subscales reflecting perceived availability of Appraisal (advice or guidance), Belonging 
(empathy, acceptance, concern), and Tangible social support (help or assistance, including 
material and financial aid). The Brief Symptom Inventory (Derogatis and Melisaratos, 1983) 
quantifies somatic and psychological symptoms of all major mental disorders. For this study 
we used Item 9 “thoughts of ending own life” as a measure of suicidal ideation over the past 
week. Additional psychometric and biometric measurements were also collected as part of a 
larger study of MDD.   
 
2.3 Blood collection and processing  
Venepuncture occurred between 9-11 am. Blood (8mL) was collected from a vein in the 
cubital fossa into tubes with EDTA then immediately placed on ice. Aprotinin was added 
(25μL/mL blood) within 5 minutes of collection. Within 20 minutes of collection, blood was 
centrifuged at 2800rpm and 4oC for 10 minutes, and then plasma was aliquoted and stored at 
-80oC until analysis. Plasma cortisol and oxytocin were measured using a standard ELISA 
method with detection at 450nm. Samples and standards were run in triplicate. The cortisol 
assay had a sensitivity of 2.44 ng/mL with intra-assay and inter-assay variance of less than 
9% and 10%, respectively.  The oxytocin assay had a sensitivity of 15pg/mL with intra-assay 
and inter-assay variance of less than 14% and 17%, respectively.   
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2.4 Statistical analyses  
A chi square test was used to compare sex distributions in the MDD versus healthy 
control groups. Prior to analysis, data were examined for outliers and deviations from 
normality. To correct for skew, the DASS, ISEL and BSI data were log transformed and 
analyses were performed on both the untransformed and transformed data. The results were 
found to be the same; hence only the untransformed data are reported. Prior to analyses, raw 
cortisol and oxytocin values were log transformed to better approximate normal distributions. 
Two-way Group (MDD, control) by Sex (male, female) ANOVAs were used to compare the 
effects and interactions of clinical status and sex on each study variable. Pearson correlations 
were used to assess relationships between the variables. Hierarchical multiple regressions 
were employed to investigate whether cortisol and oxytocin accounted for unique variance in 
help-seeking intentions beyond that explained by symptom severity and psychosocial 
variables.  
 
3. Results  
3.1 Participant characteristics and psychometrics 
Table 1 shows participant characteristics. Venepuncture was unsuccessful for two participants 
and another participant did not complete all questionnaires, resulting in complete data sets for 
60 controls and 60 participants with MDD. The groups did not differ significantly on age. 
There were 35 females in each group, 25 males in the control group and 28 males in the 
depressed group. The distribution of sexes between the groups was not statistically significant 
X
2
 (2, N = 123) = 0.1, p = .76. Two-way ANOVAs with diagnostic Group (MDD, control) and 
Sex (female, male) as between-group factors indicated that there were no significant 
differences between males and females, and no Sex by Group interactions for any of the study 





Participants with MDD had higher cortisol, lower oxytocin, and higher psychopathology 
(DASS total, Depression, Anxiety and Stress) than controls (Table 1). Help-seeking intentions 
were significantly lower in the MDD than control groups for informal sources and overall, but 
did not differ significantly between groups for formal sources of help. Perceived social 
support (ISEL-12) did not differ significantly between groups. Suicidal ideation (BSI Item 9) 
was higher in the MDD than control groups.  
 
Table 2 shows rank-ordered reasons given by depressed participants for not being in treatment 
for their current MDD. The most commonly reported reasons were “side effects of 
medication” and “unsure/ don’t know”.   
3.2 Correlational analyses  
Correlations between variables are shown in Table 3. Cortisol correlated positively with 
psychopathology (DASS Total) and suicidal ideation (BSI Item 9) and negatively with help-
seeking intentions from informal sources, and overall help-seeking intentions (GHSQ). 
Oxytocin correlated positively with GHSQ help-seeking intentions from informal and all 
sources overall. Psychopathology correlated with suicidal ideation and lower help-seeking 
intentions from informal and overall sources. Help-seeking intentions from informal sources 
correlated positively with perceived social support (ISEL-12) and inversely with suicidal 
ideation. Help-seeking from formal sources correlated only with overall help-seeking 
intentions. Overall help-seeking intentions correlated positively with perceived social support 
and inversely with suicidal ideation. Perceived social support also correlated inversely with 
suicidal ideation. The pattern of correlations between help-seeking intentions and other 
measures was similar at the single item level to the subscale level, with no types of formal 
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help (internet, telephone or face-to-face modes) correlating with hormones,  and all types of 
informal help (friends, relatives, partner) correlating with hormones. Therefore the results are 
reported at the subscale rather than single-item level.  
  
3.3 Hierarchical multiple regression  
A hierarchical multiple regression was employed to investigate whether cortisol and oxytocin 
accounted for unique variance in informal help-seeking intentions beyond that explained by 
psychopathology (DASS Total and BSI suicidal ideation) and perceived social support (ISEL-
12; Table 4). Because help-seeking intentions from formal sources did not correlate 
significantly with any other key study measures, a regression analysis was not performed for 
formal help-seeking intentions. Also, while overall help-seeking intentions correlated with 
cortisol and oxytocin levels, because only the informal help-seeking subscale was correlated 
with hormonal measures, we did not perform a regression to investigate the value of 
hormones in predicting overall help-seeking intentions. 
 
For the regression analysis, psychopathology (DASS total), perceived social support (ISEL-
12) and suicidal ideation (BSI Item 9) were entered into the first step as control variables, 
then cortisol and oxytocin levels were entered into the second step. In the first model which 
included psychopathology, suicidal ideation and perceived social support, only 
psychopathology (DASS; β = -.35, p <.001) emerged as a significant predictor of intentions to 
seek informal help. When cortisol and oxytocin were entered into the second step of the 
regression, both emerged as significant predictors of intentions to seek informal help, (β = -
.24, p =.01 and β = .21, p =.01, respectively) and psychopathology (DASS) was no longer a 
significant independent predictor of informal help-seeking intentions. Overall, the second 
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regression model was significant and accounted for 30% of the variance in intentions to seek 
informal help, F = 9.68, p < .001, R
2 
= .30 (Table 4).  
4. Discussion  
 
We investigated whether biological factors are associated with the widespread avoidance of 
help and treatment observed in depression. This represents a novel approach because previous 
studies that have sought to understand help-negation for mental health problems have 
concentrated on psychosocial issues and largely overlooked the possible role of biological 
pathways in avoidance and withdrawal from help and treatment in MDD.  
 
The hypothesis that help-seeking intentions, particularly from informal sources, would be 
lower in participants with MDD than healthy controls was supported. Additionaly, the 
severity of psychopathology and suicidal ideation correlated negatively with informal and 
overall help-seeking intentions. These results are consistent with previous studies which have 
found help-seeking intentions to be inversely related to the severity of mental health 
problems, consistent with a help-negation effect (e.g. Carlton and Deane, 2000; Rudd et al., 
1995; Sawyer et al., 2012). As in previous studies, we found important distinctions between 
help-seeking intentions from formal versus informal sources. Participants with MDD had 
lower intentions than controls to seek help from informal sources, however there were no 
between-group differences for formal help-seeking intentions, with mean responses in both 
groups being mid-range between unlikely and likely for intentions to seek help. Our findings 
with a clinically depressed sample are similar to previous ones in subclinical populations 
which showed that the help-negation effect does not seem to apply strongly to formal sources 
of help (Frost et al., 2017; Yakunina et al., 2010). Our results are also consistent with 
previous evidence that depressive symptoms are associated with lower intentions to seek help 
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from family and friends, but no effect on intentions to seek help from healthcare professionals 
(Chin et al., 2015). Chin et al.(2015) interpreted their results in psychosocial terms, that a 
depressed mood and negative thinking may make individuals reluctant to share their problems 
with family and friends as they may feel burdensome or pessimistic.  
In the current study we looked beyond psychosocial factors to investigate the novel 
hypothesis that help-negation is related to neuroendocrine changes associated with 
depression. Specifically, we predicted that cortisol would be positively related to 
psychopathology and suicidal ideation and negatively related to perceived social support and 
help-seeking intentions, and the opposite pattern would be observed for oxytocin. This 
hypothesis was partially supported, as overall and informal help-seeking intentions were 
related to these neuroendocrine markers, psychopathology, suicidal ideation and perceived 
social support in the predicted directions. Our results indicated that cortisol was positively 
associated with symptom severity and suicidal ideation and negatively associated with help-
seeking intentions. This pattern of results indicates that cortisol may be a common factor 
contributing to the help-negation effect, that is higher psychopathology and suicidal ideation 
being related to lower help-seeking intentions, found in this and previous studies (e.g. Clark 
and Fawcett, 1992; Rudd et al., 1995). Participants with MDD had higher mean morning 
cortisol levels than control participants, consistent with previous research indicating 
involvement of the HPA-axis in depression (Herbert, 2013). The correlation between suicidal 
ideation and cortisol is consistent with studies which have found that disturbances in HPA-
axis function and cortisol are linked to suicide (Jokinen and Nordström, 2009). 
 
In our study, participants with MDD had lower oxytocin levels compared to controls. Similar 
findings have been reported previously in small samples of depressed females (Ozsoy et al., 
2009; Yuen et al., 2014). Overall, however, very few previous studies have examined 
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oxytocin levels in MDD versus healthy controls, and findings are inconsistent (Massey et al., 
2016). This may be due to small sample sizes, heterogeneity in study designs, and other 
methodological limitations (Massey et al., 2016). The current results suggest a need for 
further research into relationships between depressive symptoms and oxytocin. Higher 
oxytocin levels were associated with greater intentions to seek help from informal sources for 
depressive symptoms. Additionally, perceived social support was positively correlated with 
help-seeking from informal sources, indicating that those who expressed higher help-seeking 
intentions from informal sources tended to perceive closer interpersonal bonds with friends 
and family, as well as having higher oxytocin levels. Animal research indicates that oxytocin 
plays key roles both in pro-social and anti-social behaviour (Smith et al., 2017). Oxytocin 
buffers stress in the context of social behaviour, decreasing anxiety and helping animals to 
overcome their natural avoidance of proximity, inhibiting defensive behaviour, and 
facilitating approach behaviour (reviewed in Heinrichs et al., 2009). The current results 
indicate that impairment in the oxytocinergic system in depression may be related to both 
interpersonal difficulties and reduced help-seeking from friends and family. 
 
The hypothesis that cortisol and oxytocin levels would be more closely related to informal 
than formal help-seeking intentions was also supported, with only informal help-seeking 
intentions correlating with neuroendocrine and psychosocial variables. Our results provide 
novel evidence for separate processes being involved in informal versus formal help-seeking, 
with the former being an interpersonal process related to psychosocial and neuroendocrine 
function. Social and emotional difficulties are closely interwoven in depression (Rottenberg 
and Gotlib, 2004). Stressful interpersonal relationships are risk factors for depression (Joiner, 
2014), and in turn those providing informal support can become frustrated with the depressed 
individual and reject them (Rottenberg and Gotlib, 2004). Interpersonal therapy (IPT) is 
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efficacious in reducing depressive symptoms through improving depressed individuals’ social 
functioning, however the mechanisms through which it brings about changes remain largely 
unknown (Rottenberg and Gotlib, 2004). The current results for help-seeking and perceived 
social support, in the context of previous psychosocial literature, lead to the suggestion that 
lower intentions to approach friends and family for help in MDD are related to interpersonal 
difficulties observed in depression and that both may be underpinned by neuroendocrine 
pathways which are involved in depression, stress and affiliation, modulated in part by 
cortisol and oxytocin.  
 
We also predicted that cortisol and oxytocin would both uniquely predict variance in help-
seeking intentions after accounting for levels of psychopathology and perceived social 
support. This hypothesis was supported for informal help-seeking intentions only, with both 
oxytocin and cortisol levels being statistically significant unique contributors to help-seeking 
intentions from informal sources, after accounting for symptom severity, perceived social 
support and suicidal ideation. This provides the first evidence, to our knowledge, of 
neuroendocrine involvement in predicting mental health help-seeking.   
 
Cortisol and oxytocin did not correlate with each other, but were independently correlated 
with other psychosocial variables and uniquely predicted help-seeking intentions. Previous 
studies show variability in the correlation between oxytocin and cortisol across populations, 
and laboratory tasks (Brown et al., 2016). Previous research indicates that oxytocin and 
cortisol may correlate with psychometric measures independently, but not with each other 
(Gordon et al., 2008). This has been interpreted to indicate that complex social behaviour is 
shaped by both neuro-endocrine systems, with each independently predicting different 
17 
 
psychosocial measures (Feldman et al., 2007; Gordon et al., 2008). 
 
The current results did not differ between males and females. Previous neuroendocrine 
research often has uneven sex ratios (MacDonald and MacDonald, 2010), and while some 
cortisol and oxytocin studies show sex effects or interactions, these are inconsistent 
(MacDonald and MacDonald, 2010; Young and Korszun, 2010). A meta-analysis of cortisol 
in MDD concluded that depression seems to elevate cortisol levels equally in men and women 
(Stetler and Miller, 2011), consistent with our results. Females are more likely to experience 
MDD than males (Angst et al., 2002; Kessler, 2003). The extent to which this is related to 
biological vulnerabilities versus gender-related environments is unclear (Kessler, 2003). 
Formal treatment-seeking is higher in females than males (Angst et al., 2002), however our 
sample excluded people who were receiving or seeking any treatment and thus may have been 
more homogeneous in this respect. Informal help-seeking levels may be similar between 
males and females (Angst et al., 2002). Overall our results suggest an equivalent role of 
cortisol and oxytocin in predicting help-seeking intentions for depressive symptoms in both 
sexes. 
 
While the neuroendocrine biomarkers provide some insight into biological pathways 
associated with help-negation, we found no correlations between help-seeing intentions from 
formal sources including health care professionals, and symptom severity, or psychosocial or 
biological variables. Further, when participants with MDD were asked why they were not 
seeking treatment, the most frequently given reasons were concerns about side effects of 
medication or simply unsure/ no reason. We found little evidence of stigma being a barrier to 
seeking professional treatment in the current sample. While the neuroendocrine results apply 
only to informal help-seeking, they may still have implications for treatment uptake, 
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adherence and outcomes in MDD. Help-seeking is not an isolated, rational action, but a 
process which involves influence from individuals’ social network including friends and 
family (Lindsey et al., 2010). Informal supports may help to confirm the presence of a 
problem and influence help-seeking behaviour and recovery by providing emotional support, 
reminding and helping the depressed person to attend appointments, and promoting adherence 
to treatment (Chin et al., 2015; Lindsey et al., 2010). Informal sources of help have been 
recognised as important gateways to treatment for mental health problems, and important 
points of intervention in suicidal behaviour (Barnes et al., 2002). Our results are therefore 
potentially clinically relevant and indicate a need for increased awareness of the role of 
biological factors in withdrawal from informal support in depression, which may have 
downstream effects on formal help-seeking.  
 
The results of this study have implications for understanding depressive disorders, which 
represent a large burden of untreated illness. Help-negation in MDD is a process associated 
with poorer outcomes, long term impairment and suicide risk (Stanley et al., 2015).This study 
provides preliminary evidence to support the development of a biopsychosocial model to 
better understand the widespread reluctance of depressed individuals to seek help and 
treatment. It is hoped that developing more comprehensive models to incorporate biological 
processes including those mediated by oxytocin and cortisol may lead to novel interventions 
which could reduce transitions to social withdrawal and suicidal behaviours in high risk 
individuals.  
 
If the widespread avoidance of help and withdrawal from family and friends in MDD can be 
understood as a commonly occurring response to chronic stress and associated 
neuroendocrine changes in MDD, it may facilitate problem-solving. There is some evidence 
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that education about biological aetiological factors of depression is associated with increased 
empowerment, motivation and preference for treatment, and decreased stigma (Goldstein and 
Rosselli, 2003). Additionally, biological education about depression significantly increases 
willingness to seek help, but de-stigmatisation education does not (Han et al., 2006). This is 
possibly because biological education legitimises depression as a disease entity, which 
increases motivation to solve the problem. Destigmatisation, on the other hand, reduces 
people’s negative appraisals of the depressed individuals, but may not increase people’s 
motivation to seek help (Han et al., 2006). Our results also suggest that iatrogenic concerns 
may deserve more direct attention as barriers to seeking treatment for MDD. 
 
Further research is needed to determine whether oxytocin administration might offer an 
adjunctive treatment along the pathway between HPA axis activation, depressive symptoms 
and withdrawal from help. Previous research indicates that social support and intranasal 
oxytocin both show stress reduction and anxiolytic effects, which are stronger when 
combined (Heinrichs et al., 2003). There have been no long term randomised controlled trials 
(RCTs) of oxytocin administration in MDD. Given the evidence for the involvement of 
oxytocin in the stress response, mood and interpersonal function, there is a need for RCTs of 
oxytocin as an adjunctive treatment in MDD (Cochran et al., 2013). 
 
4.1 Limitations and future directions 
 
We analysed data at a single time point only, and further, longitudinal, studies are needed to 
better understand the role of the HPA axis function in this context, and to determine causal 
relationships between the variables. We quantified only two hormones and there are likely to 
be complex interactions with other neurobiological pathways in depression that warrant 
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further investigation. However, is a strength of the study that we employed a multi-systems 
approach, examining markers of two endocrine systems in relation to psychosocial 
responding, because multi-systems approaches may aid the construction of more meaningful 
and complete models of biological systems involved in mental and physical health (Laurent et 
al., 2016). Future research is needed to determine whether interventions aimed at changing 
oxytocin or cortisol levels will have a positive effect on interpersonal relationships in people 
with MDD and their help-seeking intentions. Although we included a measure of perceived 
social support, it would also be of interest to examine other measures of interpersonal 
functioning in relation to help-seeking and hormones. Finally, we measured help-seeking 
intentions rather than actual help-seeking behaviours. Previous research indicates that the two 
are correlated (e.g. Wilson et al., 2005), however intentions differ from actual help-seeking 
behaviour, so further assessment of behaviours would be useful.  
4.2 Conclusions 
The results provide new information about interactions of psychosocial and neurobiological 
factors which may help to explain why those with depressive symptoms are often reluctant to 
seek help. More specifically, they indicate that help-seeking intentions from friends and 
family are related to cortisol and oxytocin levels, symptom severity and perceived social 
support, with the strongest predictors being cortisol and oxytocin. Lower help-seeking 
intentions in MDD may be related to HPA axis activity, and dysfunctions in oxytocin 
metabolism associated with depression. Further research is needed to ascertain whether 
interventions aimed at changing hormone levels can improve interpersonal difficulties in 
MDD. In the meantime, education regarding the involvement of biological factors in 
reluctance to seek help for depressive symptoms and the importance of social support could 
form the basis for new approaches to help and engage individuals with MDD, which go 









Descriptive data and analyses of variance between depressed and healthy controls for 
demographic, hormonal and psychometric study variables. 
  Depressed Control  
  
Variable Mean (SD) Mean (SD) F p 
     














Psychopathology DASS   Total 58.7 (26.51) 21 (18.32) 83.38 <.0001 
  Depression 23.21 (9.38) 6.2 (7.41) 123.76 <.0001 
  Anxiety 13.59 (10.65) 4.50 (5.57) 34.68 <.0001 
  Stress 21.90 (9.6) 10.30(7.97) 52.95 <.0001 
Help-seeking intentions GHSQ Informal 2.94(1.29) 4.5(1.44) 39.97 <.0001 
  Formal 3.51(1.51) 3.41(1.32) 0.15 0.7 
 
All sources 3.02 (.96) 3.64(.96) 12.57 0.001 




Suicidal Ideation BSI Item 9 .76 (1.12) .13 (.50) 15.91 <.0001 
  Note: DASS= Depression, Anxiety and Stress Scales; GHSQ = General Help-Seeking 









Rank- ordered reasons given by depressed participants for 
not seeking treatment. 
 
Self-reported reasons by depressed 
participants for not seeking treatment 
n (%) 
Previously had side effects from medication 
 
15 (24) 
Not sure/ no reason 
 
14 (22) 
Doesn’t want to take medications 
 
9 (14) 
Prefers to manage alone 
 
6 (10) 




Didn’t think treatment necessary/ waiting for 
problems to go away 
 
4 (6) 




No motivation for treatment 
 
4 (6) 






Doesn’t trust health professionals  
 
2 (3) 
Cost of treatment 
 
2 (3) 
Prefers to use exercise to manage 
 
2 (3) 
Culturally unacceptable to seek treatment 
 
1 (2) 
Forgets to take medication 
 
1 (2) 
Note. The percentages do not sum to 100% because participants could give multiple reasons 






        
 
Pearson's Correlations for Study Variables  
 
     
                  
Variable    1 2 3 4 5 6 7 
1.       Cortisol 
       
2.       Oxytocin 0.11 
      
3.       Psychopathology  DASS Total .49** -0.14      
4.       Help-seeking Informal GHSQ -.35** .22* -.47**     
5.       Help-seeking Formal GHSQ -0.02 0.02 -0.06 0.09    
6.       Help-seeking All Sources GHSQ 
       
-.24** .19* -.37** .74** .71** 
  
7.       Perceived Social Support ISEL-12  0.02 0.07 -.26** .25** 0.13     .27**  
 
8.       Suicidal ideation  BSI Item 9 
            
  
.33** 0.02 .55** -.37** -0.12 
   
 -.35** 
  
   
 -.37** 
  
Note: DASS = Depression, Anxiety and Stress Scales; GHSQ = General Help-Seeking Questionnaire; ISEL-12 = Interpersonal Support Evaluation List-12; 
BSI =Brief Symptom Inventory. 
*p < .05, **p < .01 
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Table 4          
  
Summary of Hierarchical Multiple Regression Analyses Predicting Help-Seeking Intentions from Informal Sources   
          
Predictor     R² Adjusted R² ∆R² B  SE B β p 
          
Step 1   .23 .21  .23**     
    Psychopathology DASS Total     -.02 .01    -.35  <.01** 
    Suicidal ideation BSI Item 9     -.21 .17    -.13    .20 
    Perceived social support ISEL-
12      .04 .03     .11 
   .13 
Step 2       .30        .27    .07*     
    Psychopathology DASS Total      -.01      .01   -.20    .06 
    Suicidal ideation BSI Item 9                  -.22 .17   -.13    .20 
    Perceived social support ISEL-12                   .05 .03   .16    .07 
    Cortisol                  -.003 .00  -.24    .01* 
    Oxytocin                     .002 .00   .21    .01* 
Note. SE = Standard Error, DASS = Depression, Anxiety and Stress Scales; GHSQ = General Help-Seeking Questionnaire; ISEL-12 = 
Interpersonal Support Evaluation List-12; BSI =Brief Symptom Inventory. 
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